242 related articles for article (PubMed ID: 35038203)
1. Value of T
Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
[TBL] [Abstract][Full Text] [Related]
2. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
4. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.
Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
6. Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness.
Hectors SJ; Said D; Gnerre J; Tewari A; Taouli B
J Magn Reson Imaging; 2020 Jul; 52(1):271-279. PubMed ID: 31961049
[TBL] [Abstract][Full Text] [Related]
7. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.
Panda A; Obmann VC; Lo WC; Margevicius S; Jiang Y; Schluchter M; Patel IJ; Nakamoto D; Badve C; Griswold MA; Jaeger I; Ponsky LE; Gulani V
Radiology; 2019 Sep; 292(3):685-694. PubMed ID: 31335285
[TBL] [Abstract][Full Text] [Related]
8. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
[No Abstract] [Full Text] [Related]
9. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
[TBL] [Abstract][Full Text] [Related]
10. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
11. Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection.
Ziayee F; Ullrich T; Blondin D; Irmer H; Arsov C; Antoch G; Quentin M; Schimmöller L
PLoS One; 2021; 16(4):e0249532. PubMed ID: 33819295
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
Cui Y; Han S; Liu M; Wu PY; Zhang W; Zhang J; Li C; Chen M
J Magn Reson Imaging; 2020 Aug; 52(2):552-564. PubMed ID: 32027071
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
15. Amide Proton Transfer Could Provide More Accurate Lesion Characterization in the Transition Zone of the Prostate.
Guo Z; Qin X; Mu R; Lv J; Meng Z; Zheng W; Zhuang Z; Zhu X
J Magn Reson Imaging; 2022 Nov; 56(5):1311-1319. PubMed ID: 35429190
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
17. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
18. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
19. Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer.
Rudolph MM; Baur ADJ; Haas M; Cash H; Miller K; Mahjoub S; Hartenstein A; Kaufmann D; Rotzinger R; Lee CH; Asbach P; Hamm B; Penzkofer T
Eur Radiol; 2020 Aug; 30(8):4262-4271. PubMed ID: 32219507
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
